FDA updates labeling for BELBUCA
Labeling changes approved for BDSI. Active ingredient: BUPRENORPHINE HYDROCHLORIDE. Decision date: 12/22/2025
Labeling changes approved for BDSI. Active ingredient: BUPRENORPHINE HYDROCHLORIDE. Decision date: 12/22/2025
There are no comments here yet...